Influx Healthtech Limited (NSE:INFLUX)
India
· Delayed Price · Currency is INR 221.95
+12.90 (6.17%)
At close: Mar 6, 2026
Influx Healthtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 1,236 | 1,049 | 999.65 | 760.57 | 592.02 | - |
| Revenue Growth (YoY) | 62.46% | 4.89% | 31.44% | 28.47% | - | - |
| Cost of Revenue | 717.66 | 639.48 | 656.01 | 528.63 | 456.38 | - |
| Gross Profit | 517.93 | 409.05 | 343.65 | 231.94 | 135.64 | - |
| Selling, General & Admin | 112.08 | 100.29 | 82.21 | 61.45 | 39.8 | 0.03 |
| Other Operating Expenses | 142.83 | 102.06 | 91.61 | 63.25 | 34.15 | 0.01 |
| Operating Expenses | 287.4 | 230.6 | 192.36 | 134.08 | 75.16 | 0.04 |
| Operating Income | 230.53 | 178.46 | 151.28 | 97.86 | 60.48 | -0.04 |
| Interest Expense | - | -0.01 | -1.71 | -0.1 | -0.05 | - |
| Interest & Investment Income | 2.19 | 0.56 | 0.23 | - | - | - |
| Currency Exchange Gain (Loss) | -0.22 | -0.22 | 0.01 | - | - | - |
| Other Non Operating Income (Expenses) | 0 | 0 | -0.48 | -0.4 | -0.37 | -0.05 |
| Pretax Income | 232.5 | 178.79 | 149.33 | 97.36 | 60.06 | -0.09 |
| Income Tax Expense | 54.94 | 45.13 | 38.05 | 25.4 | 15.69 | - |
| Net Income | 177.56 | 133.66 | 111.28 | 71.96 | 44.37 | -0.09 |
| Net Income to Common | 177.56 | 133.66 | 111.28 | 71.96 | 44.37 | -0.09 |
| Net Income Growth | 146.73% | 20.11% | 54.63% | 62.20% | - | - |
| Shares Outstanding (Basic) | 19 | 18 | 18 | 18 | 18 | 18 |
| Shares Outstanding (Diluted) | 19 | 18 | 18 | 18 | 18 | 18 |
| Shares Change (YoY) | 7.38% | - | - | -0.00% | 0.00% | - |
| EPS (Basic) | 9.11 | 7.36 | 6.13 | 3.96 | 2.44 | -0.00 |
| EPS (Diluted) | 9.11 | 7.36 | 6.13 | 3.96 | 2.44 | -0.00 |
| EPS Growth | 129.97% | 20.06% | 54.80% | 62.00% | - | - |
| Free Cash Flow | - | -11.55 | 5.83 | 19.43 | 0.49 | - |
| Free Cash Flow Per Share | - | -0.64 | 0.32 | 1.07 | 0.03 | - |
| Gross Margin | 41.92% | 39.01% | 34.38% | 30.50% | 22.91% | - |
| Operating Margin | 18.66% | 17.02% | 15.13% | 12.87% | 10.22% | - |
| Profit Margin | 14.37% | 12.75% | 11.13% | 9.46% | 7.49% | - |
| Free Cash Flow Margin | - | -1.10% | 0.58% | 2.55% | 0.08% | - |
| EBITDA | 263.61 | 206.63 | 169.74 | 107.19 | 61.7 | - |
| EBITDA Margin | 21.34% | 19.71% | 16.98% | 14.09% | 10.42% | - |
| D&A For EBITDA | 33.08 | 28.17 | 18.46 | 9.33 | 1.22 | - |
| EBIT | 230.53 | 178.46 | 151.28 | 97.86 | 60.48 | -0.04 |
| EBIT Margin | 18.66% | 17.02% | 15.13% | 12.87% | 10.22% | - |
| Effective Tax Rate | 23.63% | 25.24% | 25.48% | 26.09% | 26.13% | - |
| Revenue as Reported | 1,238 | 1,050 | 1,000 | 760.57 | 592.02 | - |
| Advertising Expenses | - | 0.19 | 0.2 | 1.25 | 0.14 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.